Search in:

Renal Failure Volume 34, 2012 - Issue 3

Submit an article Journal homepage

Free access

1,383

Views

CrossRef citations to date

Altmetric

Clinical Study

Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study

Halil Zeki TonbulDivision of Nephrology, Department of Internal Medicine, Meram School of Medicine, Selcuk University, Meram, Konya, Turkey

Yalcin SolakDivision of Nephrology, Department of Internal Medicine, Meram School of Medicine, Selcuk University, Meram, Konya, TurkeyCorrespondence[email protected]

Huseyin AtalayDivision of Nephrology, Department of Internal Medicine, Meram School of Medicine, Selcuk University, Meram, Konya, Turkey

Kultigin TurkmenDivision of Nephrology, Department of Internal Medicine, Meram School of Medicine, Selcuk University, Meram, Konya, Turkey

Lutfullah AltintepeDivision of Nephrology, Meram Research and Training Hospital, Meram, Konya, Turkey

Pages 297-303 | Received 13 Aug 2011, Accepted 01 Nov 2011, Published online: 17 Jan 2012

Cite this article
https://doi.org/10.3109/0886022X.2011.647298

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Amit Agarwal, Ranil Fernando, Rajeev Parameswaran, Anand Mishra & Roma PradhanAmit Agarwal, Ranil Fernando, Rajeev Parameswaran, Anand Mishra & Roma Pradhan. 2023. Case Studies in Thyroid and Parathyroid Tumors. Case Studies in Thyroid and Parathyroid Tumors 141 144 .

L. V. Egshatyan. (2022) Selective vitamin D receptor activator Paricalcitol and its potential benefits in hemodialysis patients with secondary hyperparathyroidism. Meditsinskiy sovet = Medical Council:10, pages 132-139.
Crossref

Zhuolin Zhang, Lele Cai, Hong Wu, Xinglu Xu, Wenqing Fang, Xuan He, Xiao Wang & Xin Li. (2021) Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis. Frontiers in Public Health 9.
Crossref

Masahide Mizobuchi, Hiroaki Ogata & Fumihiko Koiwa. (2018) Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment. Therapeutic Apheresis and Dialysis 23:4, pages 309-318.
Crossref

Jacek Zawierucha, Jolanta Malyszko, Jacek S. Malyszko, Tomasz Prystacki, Wojciech P. Marcinkowski & Teresa Dryl-Rydzynska. (2019) Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison. Frontiers in Endocrinology 10.
Crossref

Richa Pandey, Julia B. Zella, Jinge G. Zhu, Lori A. Plum, Margaret Clagett-Dame, William J. Blaser, Wendy Bedale, Hector F. DeLuca & Daniel W. Coyne. (2017) Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis. Drugs in R&D 17:4, pages 597-605.
Crossref

Mariano Rodríguez Portillo & María E. Rodríguez-Ortiz. (2017) Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies. Reviews in Endocrine and Metabolic Disorders 18:1, pages 79-95.
Crossref

Panpan Cai, Xiaohong Tang, Wei Qin, Ling Ji & Zi Li. (2016) Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. International Urology and Nephrology 48:4, pages 571-584.
Crossref

Francisco José Borrego Utiel, Juan Antonio Bravo Soto, María José Merino Pérez, Isabel González Carmelo, Verónica López Jiménez, Teresa García Álvarez, Yelenei Acosta Martínez & María Auxiliadora Mazuecos Blanca. (2015) Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism. Nefrología (English Edition) 35:4, pages 363-373.
Crossref

Francisco José Borrego Utiel, Juan Antonio Bravo Soto, María José Merino Pérez, Isabel González Carmelo, Verónica López Jiménez, Teresa García Álvarez, Yelenei Acosta Martínez & María Auxiliadora Mazuecos Blanca. (2015) Efecto de paricalcitol sobre el metabolismo mineralóseo en pacientes trasplantados renales con hiperparatiroidismo secundario. Nefrología 35:4, pages 363-373.
Crossref

Armando L. Negri & Vincent M. Brandemburg. (2014) Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism. International Urology and Nephrology 46:6, pages 1145-1151.
Crossref

M. Cozzolino, M. Ketteler, K. J. Martin, A. Sharma, D. Goldsmith & S. Khan. (2014) Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. Nephrology Dialysis Transplantation 29:4, pages 899-905.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study

Citations (12)

Articles from other publishers (12)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date